1. Home
  2. TCPC vs TECX Comparison

TCPC vs TECX Comparison

Compare TCPC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCPC
  • TECX
  • Stock Information
  • Founded
  • TCPC 2006
  • TECX 2019
  • Country
  • TCPC United States
  • TECX United States
  • Employees
  • TCPC N/A
  • TECX N/A
  • Industry
  • TCPC Finance/Investors Services
  • TECX
  • Sector
  • TCPC Finance
  • TECX
  • Exchange
  • TCPC Nasdaq
  • TECX Nasdaq
  • Market Cap
  • TCPC 665.8M
  • TECX 334.4M
  • IPO Year
  • TCPC 2012
  • TECX 2018
  • Fundamental
  • Price
  • TCPC $7.77
  • TECX $20.16
  • Analyst Decision
  • TCPC Hold
  • TECX Buy
  • Analyst Count
  • TCPC 4
  • TECX 6
  • Target Price
  • TCPC $7.50
  • TECX $78.67
  • AVG Volume (30 Days)
  • TCPC 518.6K
  • TECX 239.7K
  • Earning Date
  • TCPC 08-06-2025
  • TECX 08-13-2025
  • Dividend Yield
  • TCPC 15.21%
  • TECX N/A
  • EPS Growth
  • TCPC N/A
  • TECX N/A
  • EPS
  • TCPC N/A
  • TECX N/A
  • Revenue
  • TCPC $259,596,996.00
  • TECX N/A
  • Revenue This Year
  • TCPC N/A
  • TECX N/A
  • Revenue Next Year
  • TCPC N/A
  • TECX N/A
  • P/E Ratio
  • TCPC N/A
  • TECX N/A
  • Revenue Growth
  • TCPC 20.88
  • TECX N/A
  • 52 Week Low
  • TCPC $6.27
  • TECX $13.70
  • 52 Week High
  • TCPC $11.06
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • TCPC 54.15
  • TECX 45.05
  • Support Level
  • TCPC $7.40
  • TECX $19.25
  • Resistance Level
  • TCPC $7.78
  • TECX $20.75
  • Average True Range (ATR)
  • TCPC 0.17
  • TECX 1.39
  • MACD
  • TCPC -0.01
  • TECX -0.21
  • Stochastic Oscillator
  • TCPC 63.16
  • TECX 28.15

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: